Loading

Archive for the 'Pharma' Category

All information about Pharma, Pharma Latest News

Tax breaks key to keeping GSK business in UK

The U.K. has unveiled a tax incentive plan that would from 2013 offer companies a 10 percent tax break on revenues resulting from patents filed there. U.K.-based GlaxoSmithKline likes the sound of that. “The patent box is exactly the sort of active, long-term and creative support that we need…

Study: Bisphosphonates may cut breast cancer risk

A popular type of osteoporosis drug may reduce women’s risk of developing breast cancer, according to two

Senators take on data mining

Companies like IMS and Verispan have built major businesses by collecting data on physician prescribing habits and selling it to drugmakers. Pharma companies

Pfizer Extends Commitment to Help Unemployed Americans

Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth…

Manhattan Research Releases Physician Digital Media Planning Guide

While most marketers have accepted that nearly all physicians are online today, the more difficult part is figuring out where to find these physicians on the World Wide Web. Finding the right promotional mix for connecting with physicians can be a challenging proposition, as physicians use third-party sites – such…

Pfizer sues Dr Reddy’s over Lipitor

Pfizer is suing India’s Dr Reddy’s Laboratories in a Delaware federal court over a proposed generic version of the blockbuster cholesterol med Lipitor, according to Livemint . Dr Reddy’s notified Pfizer in October that it was seeking FDA approval for a generic version of the drug. The last-to-expire patent…

Ranbaxy to launch generic Flomax in 2010

A top Ranbaxy executive says the company will launch a generic version of Astellas Pharma’s urinary disorders

Lilly strong now, but future uncertain

Earlier this week, Bernstein Research analyst Dr. Tim Anderson said in a letter that Eli Lilly was among three Big Pharma companies facing the biggest patent losses over the next few years. Between 2011 and 2014, drugs like Zyprexa, Cymbalta, Gemzar and Evista will all go off-patent. When Lilly…

SEC probes four Pharmas for insider trading

The SEC is investigating four pharma deals as part of a larger

Drug costs doubled in one decade

Adult prescription drug expenditure doubled from 1996 to 2006, according to a report released by the Agency for Healthcare Research and Quality.